EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants

Sherifdeen Onigbinde iD, Cristian D Gutierrez Reyes iD, Mojibola Fowowe iD, Oluwatosin Daramola iD, Mojgan Atashi iD, Andrew I Bennett iD, Yehia Mechref iD

Biomolecules · 2023

DOI: 10.3390/biom13101467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Sherifdeen Onigbinde und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, Welch Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The highly glycosylated S protein plays a vital role in host cell invasion, making it the principal target for vaccine development. Differences in mutations observed on the spike (S) protein of SARS-CoV-2 variants may result in distinct glycosylation patterns, thus influencing immunological evasion, infectivity, and transmissibility. The glycans can mask key epitopes on the S1 protein and alter its structural conformation, allowing the virus to escape the immune system. Therefore, we comprehensively characterize O-glycosylation in eleven variants of SARS-CoV-2 S1 subunits to understand the differences observed in the biology of the variants. In-depth characterization was performed with a double digestion strategy and an efficient LC-MS/MS approach. We observed that O-glycosylation is highly conserved across all variants in the region between the NTD and RBD, whereas other domains and regions exhibit variation in O-glycosylation. Notably, omicron has the highest number of O-glycosylation sites on the S1 subunit. Also, omicron has the highest level of sialylation in the RBD and RBM functional motifs. Our findings may shed light on how differences in O-glycosylation impact viral pathogenicity in variants of SARS-CoV-2 and facilitate the development of a robust vaccine with high protective efficacy against the variants of concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansGlycosylationChromatography, LiquidTandem Mass SpectrometryVirulence

Stichwörter der Autor:innen

LC-MS/MSO-glycosylationSARS-CoV-2mutationspathogenicitytransmissibility

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA.

ORCID-Profile: Sherifdeen Onigbinde, Cristian D Gutierrez Reyes, Mojibola Fowowe, Oluwatosin Daramola, Mojgan Atashi, Andrew I Bennett, Yehia Mechref

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • Welch Foundation
  • The CH Foundation

Zitieren

APA

Onigbinde, S., Reyes, C. D. G., Fowowe, M., Daramola, O., Atashi, M., Bennett, A. I., & Mechref, Y. (2023). Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants. Biomolecules. https://doi.org/10.3390/biom13101467

Vancouver

Onigbinde S, Reyes CDG, Fowowe M, Daramola O, Atashi M, Bennett AI, et al. Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants. Biomolecules. 2023. doi:10.3390/biom13101467

BibTeX
@article{Onigbinde2023,
  author = {Onigbinde, Sherifdeen and Reyes, Cristian D Gutierrez and Fowowe, Mojibola and Daramola, Oluwatosin and Atashi, Mojgan and Bennett, Andrew I and Mechref, Yehia},
  title = {Variations in O-Glycosylation Patterns Influence Viral Pathogenicity, Infectivity, and Transmissibility in SARS-CoV-2 Variants},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13101467}
}
Kostenlos starten →